新产品
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| S510901 | Cenicriviroc Mesylate | 497223-28-6 | 98% Min. |  |
| Cenicriviroc（代号TAK-652，TBR-652）是用于治疗HIV感染的实验候选药物 | ||||
| 512193 | ITI-214磷酸盐 | 1642303-38-5 | 98% Min. |  |
| ITI-214 is a potent and selective phosphodiesterase 1 (PDE1) inhibitor. As the clinic | ||||
| 6111901 | UNC2541 | 1612782-86-1 | 98% Min. |  |
| UNC2541 is a potent and MerTK-specific inhibitor and exhibits sub-micro molar inhibit | ||||
| 112591 | U-73343 | 142878-12-4 | 98% Min. |  |
| U-73343 is a negative control (or inactive analogue) of U73122, which is a putative p | ||||
| 204302 | Lerociclib | 1628256-23-4 (free base) | 98% | .png) |
| Lerociclib，也称为G1T38，是一种口服，有效和选择性的CDK4 / 6抑制剂 | ||||
| S-203041 | 4-(2,2,2-三氟乙氧基)苯基硼酸 | 886536-37-4 | 95% | phenyl]boronic_acid_886536-37-4.png) |
| g scale to Kg scale may be provided. | ||||
| 262324 | 2-(3-Fluoro-4-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | 1350426-06-0 | 98% Min. | -4,4,5,5-tetramethyl-1,3,2-dioxaborolane_1350426-06-0.png) |
| 52004 | Belnacasan | 273404-37-8 | 98% | _273404-37-8.png) |
| Belnacasan (VX-765) 是 VRT-043198 的口服生物活性前药，VRT-043198 是有效 | ||||
| 2073107 | Trilaciclib hydrochloride (G1T28 hydrochloride) | 1977495-97-8 | 98% Min. |  |
| Trilaciclib是一种小分子竞争性细胞周期蛋白依赖性激酶4和6（CDK4 / | ||||
| 20103001 | ASN007 | 2055597-12-9 | ≧98.0% |  |
| ASN007 , a novel oral ERK inhibitor , has shown anti-tumor activity in both solid tum | ||||
| 20103002 | Senaparib | 1401682-78-7 | ≧98.0% |  |
| Senaparib (IMP4297) is a novel agent targeting PARP (poly-ADP ribose polymerase) with | ||||
| 201221 | Razuprotafib sodium | 1809275-69-1 | ≧98.0% |  |
| Razuprotafib，也称为AKB-9778，是血管内皮蛋白酪氨酸磷酸酶（VE-PTP） | ||||